Advertisement
Screener

RA PHARMACEUTICALS, INC. Proceeds from Stock Options Exercised

RA PHARMACEUTICALS, INC. Proceeds from Stock Options Exercised

RA PHARMACEUTICALS, INC. reported Proceeds from Stock Options Exercised of $3.99 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2020-02-27

  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2019-12-31 was $1.24M, a 245.53% increase year-over-year.
  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2019-09-30 was $997.00K, a 303.64% increase year-over-year.
  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2019-06-30 was $986.00K.
  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2019-03-31 was $769.00K.
  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2019 was $3.99M, a 408.80% increase from fiscal 2018.
  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2018 was $784.00K, a 194.74% increase from fiscal 2017.
  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2017 was $266.00K, a 144.04% increase from fiscal 2016.
  • RA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2016 was $109.00K, a 29.76% increase from fiscal 2015.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 12 month
2019-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$2.23M
derived: sum of 2 quarters · filed 2020-02-27
$3.22M
derived: sum of 3 quarters · filed 2020-02-27
$3.99M
10-K · filed 2020-02-27
2019-09-30$997.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$1.98M
derived: sum of 2 quarters · filed 2019-11-07
$2.75M
10-Q · filed 2019-11-07
$3.11M
derived: sum of 4 quarters · filed 2020-02-27
2019-06-30$986.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$1.75M
10-Q · filed 2019-08-07
$2.11M
derived: sum of 3 quarters · filed 2020-02-27
$2.36M
derived: sum of 4 quarters · filed 2020-02-27
2019-03-31$769.00K
10-Q · filed 2019-05-09
$1.13M
derived: sum of 2 quarters · filed 2020-02-27
$1.37M
derived: sum of 3 quarters · filed 2020-02-27
2018-12-31$358.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$605.00K
derived: sum of 2 quarters · filed 2020-02-27
$784.00K
10-K · filed 2020-02-27
2018-09-30$247.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$426.00K
10-Q · filed 2019-11-07
2018-06-30$179.00K
10-Q · filed 2019-08-07
2017-12-31$22.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$101.00K
derived: sum of 2 quarters · filed 2019-03-07
$225.00K
derived: sum of 3 quarters · filed 2019-03-07
$266.00K
10-K · filed 2019-03-07
2017-09-30$79.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$203.00K
derived: sum of 2 quarters · filed 2018-11-07
$244.00K
10-Q · filed 2018-11-07
$244.00K
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30$124.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$165.00K
10-Q · filed 2018-08-08
$165.00K
derived: sum of 3 quarters · filed 2018-08-08
$231.00K
derived: sum of 4 quarters · filed 2018-08-08
2017-03-31$41.00K
10-Q · filed 2018-05-09
$41.00K
derived: sum of 2 quarters · filed 2018-05-09
$107.00K
derived: sum of 3 quarters · filed 2018-05-09
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$66.00K
derived: sum of 2 quarters · filed 2018-03-14
$109.00K
10-K · filed 2018-03-14
2016-09-30$66.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$109.00K
10-Q · filed 2017-11-09
2016-06-30$43.00K
10-Q · filed 2017-08-09
2015-12-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$84.00K
10-K · filed 2018-03-14
2015-09-30$76.00K
10-Q · filed 2016-11-29
2014-12-31$13.00K
10-K · filed 2017-03-06